• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

18F-FDG-PET和PET/CT在接受钇-90选择性内照射治疗的结直肠癌肝转移患者中的作用：一项基于证据的首次综述。

The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based review.

作者信息

Annunziata Salvatore, Treglia Giorgio, Caldarella Carmelo, Galiandro Federica

机构信息

Department of Bioimaging and Radiological Sciences, Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy.

Department of Nuclear Medicine and PET Center, Oncology Institute of Southern Switzerland, via Ospedale 12, 6500 Bellinzona, Switzerland.

出版信息

ScientificWorldJournal. 2014 Feb 2;2014:879469. doi: 10.1155/2014/879469. eCollection 2014.

DOI:10.1155/2014/879469
PMID:24672385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3929576/
Abstract

PURPOSE

To provide a first evidence-based review of the literature on the role of fluorine-18-fluorodeoxyglucose positron emission tomography and positron emission tomography/computed tomography (FDG-PET and PET/CT) in patients with colorectal liver metastases (CRLM) undergoing selective internal radiation therapy (SIRT) with yttrium-90 ((90)Y) microspheres.

METHODS

A comprehensive computer literature search was conducted to find relevant published articles on whole-body FDG-PET or PET/CT in patients with CRLM undergoing SIRT.

RESULTS

We identified 19 studies including 833 patients with CRLM undergoing SIRT. The role of FDG-PET or PET/CT was analysed in treatment planning, treatment response evaluation, and as prognostic tool.

CONCLUSION

FDG-PET and PET/CT provide additional information in treatment evaluation of CRLM patients treated with SIRT and may have a role in treatment planning and patient selection. FDG-PET/CT is emerging as good prognostic tool in these patients.

摘要

目的

对有关氟-18-氟脱氧葡萄糖正电子发射断层扫描和正电子发射断层扫描/计算机断层扫描（FDG-PET和PET/CT）在接受钇-90（90Y）微球选择性内放射治疗（SIRT）的结直肠癌肝转移（CRLM）患者中的作用的文献进行首次循证综述。

方法

进行全面的计算机文献检索，以查找有关接受SIRT的CRLM患者全身FDG-PET或PET/CT的相关已发表文章。

结果

我们确定了19项研究，包括833例接受SIRT的CRLM患者。分析了FDG-PET或PET/CT在治疗计划、治疗反应评估以及作为预后工具方面的作用。

结论

FDG-PET和PET/CT在接受SIRT治疗的CRLM患者的治疗评估中提供了额外信息，可能在治疗计划和患者选择中发挥作用。FDG-PET/CT正在成为这些患者良好的预后工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4af/3929576/fdd17247cdf2/TSWJ2014-879469.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4af/3929576/fdd17247cdf2/TSWJ2014-879469.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4af/3929576/fdd17247cdf2/TSWJ2014-879469.001.jpg

相似文献

1
The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based review.18F-FDG-PET和PET/CT在接受钇-90选择性内照射治疗的结直肠癌肝转移患者中的作用：一项基于证据的首次综述。
ScientificWorldJournal. 2014 Feb 2;2014:879469. doi: 10.1155/2014/879469. eCollection 2014.
2
The prognostic value of quantitative parameters of 18F-FDG PET/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancer.18F-FDG PET/CT定量参数在评估结直肠癌肝转移患者钇-90内放射治疗反应中的预后价值。
Nucl Med Commun. 2013 May;34(5):501-6. doi: 10.1097/MNM.0b013e32835f9427.
3
Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer.验证基于 18F-FDG PET 的多个 SUV 相关参数在预测结直肠癌肝转移 SIRT 后生存中的作用。
J Nucl Med. 2013 Aug;54(8):1202-8. doi: 10.2967/jnumed.112.116426. Epub 2013 May 31.
4
Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.通过[18F]FDG PET评估不可切除的结直肠癌肝转移灶的90Y玻璃微球治疗反应：与CT或MRI的比较
Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):815-20. doi: 10.1007/s00259-002-0787-4. Epub 2002 Mar 29.
5
18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.18F-FDG PET/CT 预测乳腺癌肝转移放射性栓塞治疗后的生存情况。
J Nucl Med. 2012 Mar;53(3):371-7. doi: 10.2967/jnumed.111.096230. Epub 2012 Feb 13.
6
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on F-FDG.正电子发射断层扫描/计算机断层扫描（PET/CT）在结直肠癌肝转移评估中的应用：一项全面综述，重点关注 F-FDG。
Clin Exp Metastasis. 2023 Dec;40(6):465-491. doi: 10.1007/s10585-023-10231-9. Epub 2023 Sep 8.
7
Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors.选择性动脉内放射性核素治疗用钇-90（Y-90）微球治疗不可切除的原发性和转移性肝肿瘤。
World J Surg Oncol. 2011 Aug 6;9:86. doi: 10.1186/1477-7819-9-86.
8
Treatment response in liver metastases following 90Y SIR-spheres: an evaluation with PET.90Y 钇微球治疗后肝转移灶的治疗反应：PET 评估
Hepatogastroenterology. 2007 Apr-May;54(75):910-2.
9
90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.90Y微球（TheraSphere）治疗不可切除的结直肠癌肝转移：通过[18F]氟脱氧葡萄糖正电子发射断层扫描和计算机断层成像测量在135 - 150 Gy靶向剂量下的治疗反应。
J Vasc Interv Radiol. 2005 Dec;16(12):1641-51. doi: 10.1097/01.RVI.0000179815.44868.66.
10
90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT.90Y微球治疗不可切除肝转移瘤：PET/CT上18F-FDG摄取及肿瘤大小的变化
Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):778-87. doi: 10.1007/s00259-004-1752-1. Epub 2005 Mar 17.

引用本文的文献

1
Diagnostic performance of [Ga]Ga-FAPI-04 PET vs. [F]FDG PET in detecting lymph node metastasis in digestive system cancers: a head-to-head comparative meta-analysis.[镓]Ga-FAPI-04 PET与[氟]FDG PET在检测消化系统癌症淋巴结转移中的诊断性能：一项直接比较的荟萃分析。
Front Med (Lausanne). 2025 Mar 21;12:1541461. doi: 10.3389/fmed.2025.1541461. eCollection 2025.
2
Clinical and dosimetric considerations for yttrium-90 glass microspheres radioembolization of intrahepatic cholangiocarcinoma, metastatic colorectal carcinoma, and metastatic neuroendocrine carcinoma: recommendations from an international multidisciplinary working group.钇-90玻璃微球放射性栓塞治疗肝内胆管癌、转移性结直肠癌和转移性神经内分泌癌的临床与剂量学考量：一个国际多学科工作组的建议
Eur J Nucl Med Mol Imaging. 2025 Mar 28. doi: 10.1007/s00259-025-07229-8.
3

本文引用的文献

1
Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer.验证基于 18F-FDG PET 的多个 SUV 相关参数在预测结直肠癌肝转移 SIRT 后生存中的作用。
J Nucl Med. 2013 Aug;54(8):1202-8. doi: 10.2967/jnumed.112.116426. Epub 2013 May 31.
2
Initial outcome after selective intraarterial radionuclide therapy with yttrium-90 microspheres as salvage therapy for unresectable metastatic liver disease.选择性肝内动脉放射性核素治疗（钇-90 微球）作为不可切除转移性肝疾病的挽救性治疗的初始结果。
Cancer Biother Radiopharm. 2013 Sep;28(7):534-40. doi: 10.1089/cbr.2012.1455. Epub 2013 May 6.
3
Identifying subtle differences : a radiomics model assessment for gastric schwannomas and gastrointestinal stromal tumors across risk grades.识别细微差异：一项针对不同风险等级胃神经鞘瘤和胃肠道间质瘤的影像组学模型评估
Front Oncol. 2024 Dec 18;14:1467665. doi: 10.3389/fonc.2024.1467665. eCollection 2024.
4
Radiomics in precision medicine for colorectal cancer: a bibliometric analysis (2013-2023).结直肠癌精准医学中的放射组学：一项文献计量分析（2013 - 2023年）
Front Oncol. 2024 Oct 30;14:1464104. doi: 10.3389/fonc.2024.1464104. eCollection 2024.
5
The metaverse in nuclear medicine: transformative applications, challenges, and future directions.核医学中的元宇宙：变革性应用、挑战及未来方向。
Front Med (Lausanne). 2024 Sep 20;11:1459701. doi: 10.3389/fmed.2024.1459701. eCollection 2024.
6
Head-to-head comparison of Ga-FAPI-04 PET/CT and F-FDG PET/CT in the evaluation of primary digestive system cancer: a systematic review and meta-analysis.镓标记的FAPI-04 PET/CT与氟代脱氧葡萄糖（F-FDG）PET/CT在原发性消化系统癌症评估中的头对头比较：一项系统评价和荟萃分析
Front Oncol. 2023 Jun 26;13:1202505. doi: 10.3389/fonc.2023.1202505. eCollection 2023.
7
Biological Evaluation of [F]AlF-NOTA-NSC-GLU as a Positron Emission Tomography Tracer for Hepatocellular Carcinoma.[F]AlF-NOTA-NSC-GLU作为肝细胞癌正电子发射断层显像剂的生物学评价
Front Chem. 2021 Apr 16;9:630452. doi: 10.3389/fchem.2021.630452. eCollection 2021.
8
[Importance of FDG-PET/computed tomography in colorectal cancer].[氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在结直肠癌中的重要性]
Radiologe. 2019 Sep;59(9):812-819. doi: 10.1007/s00117-019-00584-2.
9
Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.使用载有90Y的树脂微球进行挽救性放射性栓塞术后结直肠癌肝转移反应的替代影像生物标志物
AJR Am J Roentgenol. 2016 Sep;207(3):661-70. doi: 10.2214/AJR.15.15202. Epub 2016 Jul 6.
10
Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG-PET/CT）上的代谢肿瘤体积和总病变糖酵解可预测结直肠癌肝转移经（90）Y放射性栓塞后的总生存期：与SUVmax、SUVpeak和实体瘤疗效评价标准（RECIST）1.0的比较
Eur J Radiol. 2016 Jun;85(6):1224-31. doi: 10.1016/j.ejrad.2016.03.029. Epub 2016 Mar 31.
The prognostic value of quantitative parameters of 18F-FDG PET/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancer.
18F-FDG PET/CT定量参数在评估结直肠癌肝转移患者钇-90内放射治疗反应中的预后价值。
Nucl Med Commun. 2013 May;34(5):501-6. doi: 10.1097/MNM.0b013e32835f9427.
4
Quantitative p retreatment VOI analysis of liver metastases. (99m)Tc-MAA SPECT/CT and FDG PET/CT in relation with treatment response to SIRT.肝转移瘤的定量治疗前感兴趣区分析。（99m）Tc-MAA SPECT/CT和FDG PET/CT与钇90微球选择性体内放射治疗的治疗反应的关系
Nuklearmedizin. 2013;52(1):21-7. doi: 10.3413/Nukmed-0514-12-07. Epub 2013 Jan 29.
5
Patterns of failure in colorectal patients with liver metastases after yttrium-90 radioembolization.结直肠癌肝转移患者行钇-90 放射性栓塞术后的失败模式。
Am J Clin Oncol. 2014 Jun;37(3):234-40. doi: 10.1097/COC.0b013e318277d610.
6
Added value of FDG-PET imaging in the diagnostic workup for yttrium-90 radioembolisation in patients with colorectal cancer liver metastases.氟代脱氧葡萄糖正电子发射断层扫描成像在结直肠癌肝转移患者钇-90 放射性栓塞诊断中的应用价值。
Eur Radiol. 2013 Apr;23(4):931-7. doi: 10.1007/s00330-012-2693-x. Epub 2012 Oct 31.
7
FDG PET/CT as a prognostic test after 90Y radioembolization in patients with metastatic hepatic disease.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG PET/CT）作为转移性肝疾病患者接受 90Y 放射性栓塞治疗后的预后检测手段。
Clin Nucl Med. 2012 Sep;37(9):862-5. doi: 10.1097/RLU.0b013e318262af7f.
8
The role of early ¹⁸F-FDG PET/CT in prediction of progression-free survival after ⁹⁰Y radioembolization: comparison with RECIST and tumour density criteria.¹⁸F-FDG PET/CT 早期显像在 ⁹⁰Y 放射性栓塞后无进展生存预测中的作用：与 RECIST 和肿瘤密度标准的比较。
Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1391-9. doi: 10.1007/s00259-012-2149-1. Epub 2012 May 30.
9
Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial.钇-90 微球选择性内放射治疗联合化疗（chemo-SIRT）治疗结直肠癌肝转移：一项体内双臂对照的 II 期试验。
Am J Clin Oncol. 2013 Oct;36(5):455-60. doi: 10.1097/COC.0b013e3182546c50.
10
Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.18F-氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描在预测不可切除转移性肝癌患者行钇-90 放射性栓塞治疗后的生存预后中的价值。
J Vasc Interv Radiol. 2012 Jul;23(7):943-8. doi: 10.1016/j.jvir.2012.04.010. Epub 2012 May 19.